Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Metastasis Research Network (U54 Clinical Trial Not Allowed)

U.S. National Institutes of Health·United States of America

Metastasis Research Network (U54 Clinical Trial Not Allowed)

Closes 9/25/2026$1.3M – $6.8MGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Cancer Institute (NCI) is soliciting applications for research on developing a comprehensive and cohesive understanding of cancer metastasis. The NCI will support U54 Specialized Centers that together will continue to serve as the hub of the Metastasis Research Network (MetNet). Each MetNet Center should propose an overarching scientific theme that will be pursued through two or three scientific inter- and multidisciplinary basic research projects. The projects should use integrative system level approaches to elucidate and integrate a mechanistic understanding of the non-linear, dynamic, and emergent processes in metastasis. • The MetNet will have a Steering Committee as a governing body. • The Steering Committee will consist of the contact PD/PI from each awarded MetNet Research Center and NCI Project Scientists. • The MetNet Steering Committee will meet monthly and at the MetNet Annual Investigator Meeting as needed. • The NCI will support U54 Specialized Centers that together will continue to serve as the hub of the Metastasis Research Network (MetNet). • Each MetNet Center should propose an overarching scientific theme that will be pursued through two or three scientific inter- and multidisciplinary basic research projects. • The projects should use integrative system level approaches to elucidate and integrate a mechanistic understanding of the non-linear, dynamic, and emergent processes in metastasis.

Attached files

Contact

Joanna M. Watson(Program Official)

[email protected]

(240) 276-6206

Key dates

Opened
11/19/2025
Closes
9/25/2026
Projected award
3/1/2027
Duration
5 years

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
RFA-CA-27-012

Budget estimate

$1,300,000 – $6,800,000

Based on the information provided, the estimated funding for this opportunity is $6,800,000, with an award ceiling of $1,300,000. The actual budget may vary depending on the number of awards and the specific proposals submitted. The factors that may influence the likely payment range include the number of applicants, the quality of the proposals, and the availability of funds.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 82%

The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)

Closes 11/22/2028Opened 6/16/2025

U.S. National Institutes of Health·United States of America

73% match

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 1/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

72% match

Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 5/28/2027Opened 12/22/2025

U.S. National Institutes of Health·United States of America

72% match

Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)

Closes 1/24/2027Opened 6/2/2026

U.S. National Institutes of Health·United States of America

71% match

Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional)

Closes 1/25/2027Opened 8/28/2025

U.S. National Institutes of Health·United States of America

71% match

National Biomedical Research Centers (P50 Clinical Trial Optional)

Closes 1/24/2027Opened 5/12/2026

U.S. National Institutes of Health·United States of America

71% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

71% match

Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

Closes 7/5/2029Opened 6/16/2025

U.S. National Institutes of Health·United States of America

71% match

Network of the National Library of Medicine Regional Medical Libraries (UG4 Clinical Trial Not Allowed)

Closes 12/14/2026Opened 2/11/2026

U.S. National Institutes of Health·United States of America

70% match

Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure ? Clinical Research Sites (U24 Clinical Trial Not Allowed)

Closes 10/31/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

70% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

70% match

Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)

Closes 11/10/2026Opened 11/18/2025

U.S. National Institutes of Health·United States of America

70% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

70% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

70% match

Immune Tolerance Network (UM1 Clinical Trial Required)

Closes 1/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

70% match

Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Closes 6/10/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

70% match

Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)

Closes 1/11/2027Opened 9/17/2025

U.S. National Institutes of Health·United States of America

70% match

Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)

Closes 10/9/2028Opened 4/9/2026

U.S. National Institutes of Health·United States of America

69% match

Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)

Closes 5/25/2027Opened 2/11/2026

U.S. National Institutes of Health·United States of America

69% match

Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 1/13/2026

U.S. National Institutes of Health·United States of America

69% match

Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 3/18/2026

U.S. National Institutes of Health·United States of America

69% match

HIV/AIDS Clinical Trials Network Clinical Trials Units

Closes 1/21/2027Opened 4/8/2026

U.S. National Institutes of Health·United States of America

69% match

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Closes 1/7/2027Opened 12/15/2023

U.S. National Institutes of Health·United States of America

69% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

69% match

Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)

Closes 11/10/2026Opened 12/29/2025